Karyopharm Therapeutics | Driftsresultatet

Operating Profit Endring Dato
Amgen USD 1.27B 819M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Avrobio USD -22933000 90.94M 2023-09
GlaxoSmithKline GBP 1.95B 192M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Takeda JPY -49342000000 217.91B 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Xencor USD -35009000 16.74M 2023-12



Karyopharm Therapeutics Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.